Closeup of Scientific microscope data analysis in the fertility laboratory, medicine equipment research setting in lab for chemistry analysis

Featured image by Carlos Duarte/Getty Images

PE

Spectris shifts support from Advent to KKR’s $5.6B acquisition offer

Renewed bid represents a 6.3% premium to Advent overture.

UK-based precision equipment maker Spectris is backing a renewed £4.1 billion (around $5.6 billion) takeover bid from KKR, dropping its support for an acquisition offer from a consortium led by Advent International last month.

KKR’s latest offer values Spectris at £40 per share in cash, representing a 6.3% premium to an earlier bid made by the Advent-led consortium.

The Spectris board has now withdrawn its backing for the Advent offer and unanimously recommended the KKR offer, which values the company at a £4.7 billion enterprise value.

This is the second time the board has switched its backing.

Spectris—which makes high-tech instruments, test equipment and software for various industries—ditched KKR’s earlier bid last month to support a £3.8 billion offer by the Advent consortium, which also includes the Canada Pension Plan Investment Board and the Singaporean sovereign wealth fund GIC.

Featured image by Carlos Duarte/Getty Images

Learn about our editorial standards.